Immunohistochemical pitfalls in prostate pathology

Human Pathology

Volumn 43, Issue 3, 2012, Pages 313-324

  Brimo, Fadi ^a   Epstein, Jonathan I ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Basal cell; Immunohistochemistry; Mimickers; Pitfalls; Prostate; Racemase

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; BIOLOGICAL MARKER; KERATIN 34BE12 ANTIBODY; PROTEIN P63; UNCLASSIFIED DRUG;

BASAL CELL; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FALSE POSITIVE RESULT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEEDLE BIOPSY; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; REVIEW;

EID: 84856937557     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.11.005     Document Type: Article

References (38)

1. M.A. Rubin, M. Zhou, and S.M. Dhanasekaran Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer JAMA 287 2002 1662 1670 (Pubitemid 34289218)
2. M. Zhou, A.M. Chinnaiyan, C.G. Kleer, P.C. Lucas, and M.A. Rubin Alpha-methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions Am J Surg Pathol 26 2002 926 931 (Pubitemid 34747646)
3. Z. Jiang, B.A. Woda, and K.L. Rock P504S: a new molecular marker for the detection of prostate carcinoma Am J Surg Pathol 25 2001 1397 1404 (Pubitemid 33022055)
4. Z. Jiang, C.L. Wu, and B.A. Woda P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy Am J Surg Pathol 26 2002 1169 1174 (Pubitemid 34969186)
5. Z. Jiang, C.L. Wu, and B.A. Woda Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker Histopathology 45 2004 218 225 (Pubitemid 39294698)
6. L.P. Kunju, A.M. Chinnaiyan, and R.B. Shah Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer Histopathology 47 2005 587 596 (Pubitemid 41775181)
7. Z. Jiang, K.A. Iczkowski, B.A. Woda, M. Tretiakova, and X.J. Yang P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens Am J Clin Pathol 121 2004 99 107 (Pubitemid 38090160)
8. M. Zhou, H. Aydin, H. Kanane, and J.I. Epstein How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Am J Surg Pathol 28 2004 239 243 (Pubitemid 38124733)
9. R. Beach, A.M. Gown, and M.N. De Peralta-Venturina P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies Am J Surg Pathol 26 2002 1588 1596 (Pubitemid 35387221)
10. M. Zhou, Z. Jiang, and J.I. Epstein Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer Am J Surg Pathol 27 2003 772 778 (Pubitemid 36617513)
11. M. Herawi, A.V. Parwani, J. Irie, and J.I. Epstein Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion Am J Surg Pathol 29 2005 874 880 (Pubitemid 40885009)
12. N. Suh, X.J. Yang, M.S. Tretiakova, P.A. Humphrey, and H.L. Wang Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma Mod Pathol 18 2005 1217 1222 (Pubitemid 43079921)
13. B.R. Oliai, H. Kahane, and J.I. Epstein Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody Am J Surg Pathol 26 2002 1151 1160 (Pubitemid 34969184)
14. T.Z. Ali, and J.I. Epstein False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells Am J Surg Pathol 32 2008 1890 1895
15. R.B. Shah, M. Zhou, M. LeBlanc, M. Snyder, and M.A. Rubin Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer Am J Surg Pathol 26 2002 1161 1168 (Pubitemid 34969185)
16. D.M. Ramnani, and D.G. Bostwick Basal cell-specific anti-keratin antibody 34betaE12: optimizing its use in distinguishing benign prostate and cancer Mod Pathol 12 1999 443 444 (Pubitemid 29230602)
17. M. Varma, M.D. Linden, and M.B. Amin Effect of formalin fixation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues Mod Pathol 12 1999 472 478 (Pubitemid 29230607)
18. A.O. Osunkoya, D.E. Hansel, X. Sun, G.J. Netto, and J.I. Epstein Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases Am J Surg Pathol 32 2008 461 467 (Pubitemid 351398939)
19. D.E. Baydar, I. Kulac, B. Gurel, and A. De Marzo A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis Int J Surg Pathol 19 2011 131 136
20. M. Zhou, C. Magi-Galluzzi, and J.I. Epstein Prostate basal cell lesions can be negative for basal cell keratins: a diagnostic pitfall Anal Quant Cytol Histol 28 2006 125 129 (Pubitemid 44469365)
21. R. Mehra, S.A. Tomlins, and R. Shen Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer Mod Pathol 20 2007 538 544 (Pubitemid 46631996)
22. M.J. Dai, L.L. Chen, and Y.B. Zheng Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer Zhonghua Yi Xue Za Zhi 88 2008 669 673
23. J.I. Epstein, F.P. Kuhajda, and P.H. Lieberman Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder Hum Pathol 17 1986 939 942 (Pubitemid 17184320)
24. D.J. Grignon, J.Y. Ro, A.G. Ayala, D.E. Johnson, and N.G. Ordóñez Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases Cancer 67 1991 2165 2172
25. B. Bodey, B. Bodey Jr., and H.E. Kaiser Immunocytochemical detection of prostate specific antigen expression in human primary and metastatic melanomas Anticancer Res 17 1997 2343 2346 (Pubitemid 27320995)
26. G.F. Holmes, D.W. Eisele, D. Rosenthal, and W.H. Westra PSA immunoreactivity in a parotid oncocytoma: a diagnostic pitfall in discriminating primary parotid neoplasms from metastatic prostate cancer Diagn Cytopathol 19 1998 221 225 (Pubitemid 28381654)
27. J.I. Epstein PSA and PAP as immunohistochemical markers in prostate cancer Urol Clin North Am 20 1993 757 770 (Pubitemid 24141169)
28. L.P. Kunju, R. Mehra, M. Snyder, and R.B. Shah Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma Am J Clin Pathol 125 2006 675 681
29. P. Mhawech, T. Uchida, and M.F. Pelte Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma Hum Pathol 33 2002 1136 1140 (Pubitemid 35416713)
30. H. Svanholm Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase Acta Pathol Microbiol Immunol Scand A 94 1986 7 12 (Pubitemid 16013755)
31. T.F. Ford, D.N. Butcher, J.R. Masters, and M.C. Parkinson Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice Br J Urol 57 1985 50 55 (Pubitemid 15174182)
32. A.Y. Chuang, A.M. DeMarzo, R.W. Veltri, R.B. Sharma, C.J. Bieberich, and J.I. Epstein Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma Am J Surg Pathol 31 2007 1246 1255 (Pubitemid 47207130)
33. P. Mhawech-Fauceglia, S. Zhang, and L. Terracciano Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique Histopathology 50 2007 472 483 (Pubitemid 46328190)
34. A. Chaux, J. Eifler, and S. Karram Focal positive prostate-specific membrane antigen (PSMA) expression in ganglionic tissues associated with prostate neurovascular bundle: implications for novel intraoperative PSMA-based fluorescent imaging techniques Urol Oncol 2011
35. M. Kalos, J. Askaa, and B.L. Hylander Prostein expression is highly restricted to normal and malignant prostate tissues Prostate 60 2004 246 256 (Pubitemid 38971836)
36. J. Xu, M. Kalos, and J.A. Stolk Identification and characterization of prostein, a novel prostate-specific protein Cancer Res 61 2001 1563 1568 (Pubitemid 34292588)
37. T. Sheridan, M. Herawi, J.I. Epstein, and P.B. Illei The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate Am J Surg Pathol 31 2007 1351 1355 (Pubitemid 47329671)
38. J.P. Higgins, G. Kaygusuz, and L. Wang Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray Am J Surg Pathol 31 2007 673 680 (Pubitemid 46684205)